Does Dr. TUSHAR ACHARYA have financial conflicts of interest?

Dr. TUSHAR ACHARYA (M.D.) has received a total of $445 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $445 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. TUSHAR ACHARYA?

According to CMS Open Payments data, Dr. TUSHAR ACHARYA received funding from INARI MEDICAL ($137), BOEHRINGER INGELHEIM PHARMACEUTICALS ($116), and ABBOTT LABORATORIES ($91).

Does Dr. TUSHAR ACHARYA receive research grants or speaking fees?

Dr. TUSHAR ACHARYA has received $445 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. TUSHAR ACHARYA

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Cardiovascular Disease

Practice Location: TUCSON, AZ 85724

NPI Number: 1922313774

LIFETIME INDUSTRY VALUE

$445

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ACHARYA is a verified Internal Medicine, Cardiovascular Disease practitioner based in TUCSON, AZ.

Between 2021 and 2024, Dr. ACHARYA had an overall industry promotional and research financial footprint of $445 as recorded in the federal CMS Open Payments database.

$445 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ACHARYA's primary funding source is INARI MEDICAL, which accounts for $137 (representing 30.9% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

INARI MEDICAL

Rank 1

$137

30.9%

BOEHRINGER INGELHEIM PHARMACEUTICALS

Rank 2

$116

26.2%

ABBOTT LABORATORIES

Rank 3

$91

20.4%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.